Singapore, April 8 -- Globalpharma, the UAE's leading pharmaceutical manufacturer and a wholly owned subsidiary of Dubai Investments PJSC, has collaborated with India's ZIM Laboratories to bring EU-certified Oral Dispersible Film (ODF) technology to its growing portfolio.

This innovative drug technology has already received EU Good Manufacturing Practice (EU-GMP) certification, ensuring it meets the highest international quality and safety standards.

The agreement, unveiled at AIM Congress 2025 (7-9 April), underscores the UAE's growing influence in global pharmaceutical innovation and its commitment to cutting-edge healthcare solutions.

Commenting on the collaboration, Mohammed Saeed Al Raqbani, General Manager of Dubai Investments In...